Literature DB >> 8132330

Lactoferrin binds to porins OmpF and OmpC in Escherichia coli.

J Erdei1, A Forsgren, A S Naidu.   

Abstract

Lactoferrin (Lf) is an iron-binding antimicrobial protein present in milk and on mucosal surfaces, with a suggested role in preimmune host defense. Certain strains of Escherichia coli (bacterial whole cells) demonstrate specific interaction with 125I-labeled Lf. A band with a mass of approximately 37 kDa, which was reactive with horseradish peroxidase-labeled Lf, was identified in the boiled cell envelope and outer membrane preparations of an Lf-binding E. coli strain, E34663, and a non-Lf-binding strain, HH45, by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting (immunoblotting). Such a band was not detected in the unboiled native cell envelope and outer membrane preparations. The molecular mass and the property of heat modifiability suggested that the Lf-binding proteins were porins. The native trimeric form of porin OmpF isolated from strain B6 and its dissociated monomeric form both reacted with horseradish peroxidase-labeled Lf and with monoclonal antibodies specific for OmpF. Furthermore, by using E. coli constructs with defined porin phenotypes, OmpF and OmpC were identified as the Lf-binding proteins by urea-SDS-PAGE and Western blotting and by 125I-Lf binding studies with intact bacteria. These data establish that Lf binds to porins, a class of well-conserved molecules common in E. coli and many other gram-negative bacteria. However, in certain strains of E. coli these pore-forming proteins are shielded from Lf interaction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132330      PMCID: PMC186264          DOI: 10.1128/iai.62.4.1236-1240.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

Review 1.  Outer membrane barrier as a mechanism of antimicrobial resistance.

Authors:  H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

2.  Human lactoferrin binding in clinical isolates of Staphylococcus aureus.

Authors:  A S Naidu; J Miedzobrodzki; J M Musser; V T Rosdahl; S A Hedström; A Forsgren
Journal:  J Med Microbiol       Date:  1991-06       Impact factor: 2.472

3.  Bovine lactoferrin binding to six species of coagulase-negative staphylococci isolated from bovine intramammary infections.

Authors:  A S Naidu; J Miedzobrodzki; M Andersson; L E Nilsson; A Forsgren; J L Watts
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

4.  Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium.

Authors:  S S Naidu; U Svensson; A R Kishore; A S Naidu
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

5.  Bacterial inhibitors in milk and other biological fluids.

Authors:  B Reite; J D Oram
Journal:  Nature       Date:  1967-10-28       Impact factor: 49.962

6.  Specific binding of lactoferrin to Escherichia coli isolated from human intestinal infections.

Authors:  S S Naidu; J Erdei; E Czirók; S Kalfas; I Gadó; A Thorén; A Forsgren; A S Naidu
Journal:  APMIS       Date:  1991-12       Impact factor: 3.205

7.  Specific binding of lactoferrin to Aeromonas hydrophila.

Authors:  A R Kishore; J Erdei; S S Naidu; E Falsen; A Forsgren; A S Naidu
Journal:  FEMS Microbiol Lett       Date:  1991-09-15       Impact factor: 2.742

8.  Lactoferrin-binding proteins in Shigella flexneri.

Authors:  Z Tigyi; A R Kishore; J A Maeland; A Forsgren; A S Naidu
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

9.  Correlation between human lactoferrin binding and colicin susceptibility in Escherichia coli.

Authors:  I Gadó; J Erdei; V G Laszlo; J Pászti; E Czirók; T Kontrohr; I Tóth; A Forsgren; A S Naidu
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

10.  Association of lactoferrin with specific granules in rabbit heterophil leukocytes.

Authors:  M Baggiolini; C De Duve; P L Masson; J F Heremans
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

View more
  17 in total

1.  In vitro growth responses of bifidobacteria and enteropathogens to bovine and human lactoferrin.

Authors:  Elizabeth A Griffiths; Linda C Duffy; Floyd L Schanbacher; Diane Dryja; Allen Leavens; Ronald L Neiswander; Haiping Qiao; Douglas DiRienzo; Pearay Ogra
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

2.  Analysis of new lactotransferrin gene variants in a case-control study related to periodontal disease in dog.

Authors:  Francisco Morinha; Carlos Albuquerque; João Requicha; Isabel Dias; José Leitão; Ivo Gut; Henrique Guedes-Pinto; Carlos Viegas; Estela Bastos
Journal:  Mol Biol Rep       Date:  2011-09-24       Impact factor: 2.316

3.  Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111.

Authors:  D S Chapple; D J Mason; C L Joannou; E W Odell; V Gant; R W Evans
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis.

Authors:  Henry F Gomez; Theresa J Ochoa; Irene Herrera-Insua; Lily G Carlin; Thomas G Cleary
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

5.  The Pepsin Hydrolysate of Bovine Lactoferrin Causes a Collapse of the Membrane Potential in Escherichia coli O157:H7.

Authors:  Christopher Murdock; Michael L Chikindas; Karl R Matthews
Journal:  Probiotics Antimicrob Proteins       Date:  2010-06       Impact factor: 4.609

6.  N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA.

Authors:  P H van Berkel; M E Geerts; H A van Veen; M Mericskay; H A de Boer; J H Nuijens
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

7.  A Salmonella typhi OmpC fusion protein expressing the CD154 Trp140-Ser149 amino acid strand binds CD40 and activates a lymphoma B-cell line.

Authors:  Mario I Vega; Leopoldo Santos-Argumedo; Sara Huerta-Yepez; Rosendo Luría-Perez; Vianney Ortiz-Navarrete; Armado Isibasi; Cesar R González-Bonilla
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

8.  Interaction of Gram-negative bacteria with cationic proteins: Dependence on the surface characteristics of the bacterial cell.

Authors:  Isabella R Prokhorenko; Svetlana V Zubova; Alexandr Yu Ivanov; Sergey V Grachev
Journal:  Int J Gen Med       Date:  2009-07-30

9.  High-resolution diffraction from crystals of a membrane-protein complex: bacterial outer membrane protein OmpC complexed with the antibacterial eukaryotic protein lactoferrin.

Authors:  N Sundara Baalaji; K Ravi Acharya; T P Singh; S Krishnaswamy
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-07-30

10.  In vitro susceptibility of established biofilms composed of a clinical wound isolate of Pseudomonas aeruginosa treated with lactoferrin and xylitol.

Authors:  Mary Cloud B Ammons; Loren S Ward; Steve T Fisher; Randall D Wolcott; Garth A James
Journal:  Int J Antimicrob Agents       Date:  2008-11-01       Impact factor: 5.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.